NCT02422498
Breast Cancer Type: Triple Negative
Hormone Mutations:
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Recruiting
Phase 2
Drug Category: Radiation Therapy, Chemotherapy
Key Eligibility Criteria:
Gender: Female
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases:
Additional Notes:
Exclusions: Brain metastases requiring focal or whole brain radiation
https://ClinicalTrials.gov/show/NCT02422498